Four cases of venous thromboembolism associated with olanzapine

Psychiatry and Clinical Neurosciences

Volumn 63, Issue 1, 2009, Pages 116-118

  Maly, Radovan ^a   Masopust, Jiri ^a   Hosak, Ladislav ^a   Urban, Ales ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Antipsychotic agents; Olanzapine; Prevention; Risk factors; Venous thromboembolism

Indexed keywords

ALPRAZOLAM; ALTEPLASE; CITALOPRAM; ESCITALOPRAM; LEVOMEPROMAZINE; LOW MOLECULAR WEIGHT HEPARIN; OLANZAPINE; OXAZEPAM; SERTRALINE; WARFARIN; ZOTEPINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DEEP VEIN THROMBOSIS; DELUSIONAL DISORDER; ECHOGRAPHY; FAMILY HISTORY; FEMALE; HOSPITALIZATION; HUMAN; LABORATORY TEST; LUNG EMBOLISM; MALE; OBESITY; SCHIZOPHRENIA; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIA, PARANOID; VENOUS THROMBOEMBOLISM;

EID: 58449112413     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01899.x     Document Type: Article

References (14)

1. Hägg S, Spigset O. Antipsychotic-induced venous thromboembolism: A review of the evidence. CNS Drugs 2002 16 : 765 776.
2. Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: A case-control study. Lancet 2000 356 : 1219 1223.
3. Hägg S, Spigset O, Söderström TG. Association of venous thromboembolism and clozapine. Lancet 2000 355 : 1155 1156.
4. Kortepeter C, Chen M, Knudsen JF, Dubitsky GM, Ahmad SR, Beitz J. Clozapine and Venous Thromboembolism. Am. J. Psychiatry 2002 159 : 876 877.
5. Waage IM, Gedde-Dahl A. Pulmonary embolism possibly associated with olanzapine treatment. BMJ 2003 327 : 1384.
6. del Conde I, Goldhaber SZ. Pulmonary embolism associated with olanzapine. Thromb. Haemost. 2006 96 : 690 691.
7. Toki S, Morinobu S, Yoshino A, Yamawaki S. A case of venous thromboembolism probably associated with hyperprolactinemia after the addition of olanzapine to typical antipsychotics. J. Clin. Psychiatry 2004 65 : 1576 1577.
8. Alhenc-Gelas M, Aiach M, de Moerloose P. Venous thromboembolic disease: Risk factors and laboratory investigation. Semin. Vasc. Med. 2001 1 : 81 87.
9. Hotoleanu C, Porojan-Iuga M, Rusu ML, Andercou A. Hyperhomocysteinemia: Clinical and therapeutical involvement in venous thrombosis. Rom. J. Intern. Med. 2007 45 : 159 164.
10. Cristina L, Benilde C, Michela C, Mirella F, Giuliana G, Gualtiero P. High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. Br. J. Haematol. 2004 124 : 504 510.
11. Kurne A, Ertugrul A, Anil Yagcioglu AE, Yazici KM. Venous thromboembolism and escitalopram. Gen. Hosp. Psychiatry 2004 26 : 481 483.
12. Graham KA, Perkins DO, Edwards LJ, Barrier RC, Lieberman JA, Harp JB. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis. Am. J. Psychiatry 2005 162 : 118 123.
13. Kamijo Y, Soma K, Naqai T, Kurihara K, Ohwada T. Acute massive pulmonary thromboembolism associated with risperidone and conventional phenothiazines. Circ. J. 2003 67 : 46 48.
14. Bhanji NH, Chouinard G, Hoffman L, Margolese HC. Seizures, coma, and coagulopathy following olanzapine overdose. Can. J. Psychiatry 2005 50 : 126 127.